胸部结外非霍奇金淋巴瘤的CT表现谱
综述全面展示胸部结外非霍奇金淋巴瘤在胸膜、肺、气道、心脏、心包、食管、胸壁和乳腺等部位的CT表现,强调影像与多种疾病重叠、单凭影像诊断困难,需对高危患者及特定征象保持较高警惕,并指出PET/CT用于常规分期、增强CT及多平面重建有助于识别细微结外病变。
要点
- 对免疫受损、自身免疫病或干细胞/实体器官移植史等高危患者,应提高结外淋巴瘤的怀疑。
- 椎体环绕征、不吸收的实变、浸润性软组织肿块及包绕血管而不侵犯的病变提示结外淋巴瘤。
- 已知NHL患者出现心包积液、胸膜软组织、肿块样实变、淋巴管周围结节或新发溶骨性骨病变提示继发受累。
核心结论
- 胸部结外非霍奇金淋巴瘤可表现为多种CT征象,与其他疾病影像重叠明显,单凭影像难以诊断,但对高危患者或具有特定影像表现者影像科医生应保持较高警惕。
- 已知NHL患者出现心包积液、胸膜软组织(即使轻微)、肿块样实变、淋巴管周围结节或新发溶骨性骨病变时,尤其提示继发受累。
研究设计与样本
- 本文为综合性综述,系统展示胸部结外非霍奇金淋巴瘤的CT表现谱。
- 涵盖部位包括胸膜、肺、气道、心脏、心包、食管、胸壁和乳腺。
- 引用文献未在摘要中说明检索范围与纳入文献数量。
关键影像表现/征象
- 椎体环绕征、不吸收的实变、浸润性软组织肿块以及包绕血管而不侵犯的病变,为提示结外淋巴瘤的影像表现。
- 心包积液、胸膜软组织(即使轻微)、肿块样实变、淋巴管周围结节和新发溶骨性骨病变,尤其提示已知NHL患者的继发受累。
临床应用与阅片要点
- 对存在免疫受损、自身免疫病或干细胞/实体器官移植史等危险因素的患者,应提高对结外淋巴瘤的怀疑。
- 对具有椎体环绕征、不吸收的实变、浸润性软组织肿块或包绕血管而不侵犯等影像表现者,应提高对结外淋巴瘤的怀疑。
- 大多数情况下,氟18标记氟脱氧葡萄糖PET/CT目前是已知NHL患者常规分期的首选方法。
- CT仍被大量使用,使用静脉对比剂并仔细审阅多平面图像可提高CT识别细微结外受累的能力。
- 当模棱两可的发现可能改变分期和治疗时,磁共振成像是有帮助的解决问题的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Non-Hodgkin lymphoma (NHL) frequently manifests in extranodal structures in the chest, often in the form of secondary involvement but occasionally as primary disease. Because staging and treatment are affected by the presence of extranodal disease at imaging, radiologists' interpretation and management of suspicious findings are critical to patient care. Unfortunately, owing to considerable imaging overlap with other diseases, primary extranodal lymphoma is difficult to diagnose with imaging alone. Radiologists should have a heightened degree of suspicion in patients at risk (including patients with immune compromise, autoimmune diseases, or a history of stem cell or solid organ transplant) or with particular imaging appearances (including the vertebral wraparound sign, nonresolving consolidation, an infiltrative soft-tissue mass, and lesions demonstrating vascular encasement without invasion). For patients with known NHL, positron emission tomography/computed tomography (PET/CT) using fluorine 18 (18F)-labeled fluorodeoxyglucose (FDG) is now preferred for routine staging in most cases. CT remains heavily used, and identification of subtle extranodal involvement with CT can be improved with use of intravenous contrast material and careful review of multiplanar images. Pericardial effusion, pleural soft tissue (even when mild), mass-like consolidation, perilymphatic nodularity, and new lytic bone lesions are particularly suggestive of secondary involvement in a patient with known NHL. Magnetic resonance imaging is a helpful problem-solving tool when equivocal findings would change staging and treatment. This comprehensive review illustrates the spectrum of CT manifestations of extranodal NHL in the chest, including the pleura, lung, airways, heart, pericardium, esophagus, chest wall, and breast. ©RSNA, 2017.
引用
- Bligh MP, Borgaonkar JN, Burrell SC, et al. Spectrum of CT Findings in Thoracic Extranodal Non-Hodgkin Lymphoma. Radiographics. 2017. PMID: 28287948. doi:10.1148/rg.2017160077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。